Pharmaceutical
Vylaer Spiromax-H-C-3952-A31-14165: EPAR - Assessment Report - Article 31
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Advanced pharmaceutical formulation for targeted therapeutic intervention.